NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric
A rubric for evaluating the FAIRness of NIH-CFDE Resources
Tags: nihcommonfund
URL(s):
View AssociationsRubric Assessments (626384)
| Assessment | Metrics | Date | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
| Cell Painting morphological profiling assay | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BS-181 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Crizotinib KINOMEscan-2 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| 5z-7-oxozeaenol KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.76) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| CP466722 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AZD1152-HQPA KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.72) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Ceritinib KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BIRB-796 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Cell signaling response to growth factors measured by ELISA | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Profiling Project, Drug Sensitivity 1: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens. Dataset 1 of 2: Normalized growth rate inhibition values. | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AB-1010 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| A549 cells -- High-throughput Secretomic Analysis of Single Cells | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.84) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| ABT-869 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AZ-628 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BI-D1870 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BI-2536 KINOMEscan-2 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| CP724714 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BX-912 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| QL-XII-47 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| ALW-II-49-7 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 3 of 3: Calculated dose-response metrics. | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AZD 5438 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Baricitinib KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
